Sarasota, FL, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 - 2022”. According to the report, global antithrombin market was valued at approximately USD 450.4 million in 2016 and is expected to generate revenue of around USD 613.8 million by end of 2022, growing at a CAGR of around 5.3% between 2017 and 2022.
Antithrombin is a protein present in the bloodstream, which functions as a naturally occurring mild blood thinner. Antithrombin helps to control too much clotting. A person with low antithrombin levels has more tendency to clot more easily. Vice-versa, if antithrombin levels are too high, a person could, theoretically, have a more bleeding tendency. However, raised levels of antithrombin do not appear to cause bleeding or have any clinical significance.
Browse through 87 Tables & 19 Figures spread over 110 Pages and in-depth TOC on "Antithrombin Market by Type, Application, Share, Analysis and Forecast 2016 – 2022”.
Request Free Sample copy of Global Antithrombin Market Report @ https://www.zionmarketresearch.com/sample/antithrombin-market
The widespread use of antithrombin for the treatment of various medical conditions such as extracorporeal membrane oxygenation, hereditary antithrombin deficiency, sepsis, and disseminated intravascular coagulation are the major factors responsible for the growth of global antithrombin market. Moreover, the rising adoption of antithrombin as a combination therapy with heparin is expected to open huge growth opportunities for antithrombin market.
The global antithrombin market is segmented on the basis of source, application, dosage form, and geographically. By source, the antithrombin market has been segmented as human, and goat milk. The human source, the segment is estimated to account major shares in global antithrombin market in 2016. Humans are the major source of antithrombins, but know a day’s the use of goat milk for the production of antithrombin is increasing. Goats produce about 800 liters of milk per year. As compared to cell culture model, the yield of the active protein by goat model is 10 times more. The transgenic goats are the excellent source for antithrombin production, as they produce plenty of milk in short generation time, and these factors are responsible for the high growth of goat milk segment over the forecast period. Currently, the goat milk produced antithrombins are available in developed countries such as U.S., UK, and Germany etc. The increasing adoption of newer technologies and advanced products in developing countries is expected to drive the growth of segment over the forecast period.
Browse the full "Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis, andForecast, 2016 - 2022" report at https://www.zionmarketresearch.com/report/antithrombin-market
By geographically, the global antithrombin market is segmented into five major regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Europe represents developed regional markets for antithrombin and is expected to show the rapid growth in the years to come. The Germany and U.K. is by far the leading antithrombin market by country in Europe. The U.K. market is expected to grow at the highest CAGR during the forecast period. This growth is mainly due to the well-developed healthcare infrastructure and increases in research and development activities in biopharmaceuticals. Moreover, the adoption rate of newer techniques, in this region which promotes the growth of antithrombin market.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/antithrombin-market
North America was the second largest regional market and is expected to show significant growth in the years to come. This growth is mainly due to high awareness about newer technologies and fast adoption rate.
The Asia Pacific is expected to witness noticeable growth in the near future. In Asia, China, India, and Japan will continue to be the fastest growing markets in antithrombin market. Growth in Asia Pacific market is expected to be driven increasing government support, and rising expenditure in research and development.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/2514
In Middle East & Africa; African region is projected to register noticeable growth owing to increased government funding. Latin America is another important regional market and is expected to experience moderate growth over the forecast period. Thus, all the aforementioned parameters are expected to propel the market growth in this region.
Directly Purchase a copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/antithrombin-market
Some of the key players in global Antithrombin market include Grifols, rEVO Biologics Inc., Shire plc., Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., and Lee Biosolutions among others.
For media inquiry contact our sales team @ sales@zionmarketresearch.com
This report segments the Global Antithrombin Market as follows:
Global Antithrombin Market: Source Segment Analysis
- Human
- Goat Milk
Global Antithrombin Market: Application Segment Analysis
- Diagnostics
- Therapeutics
- Research
Global Antithrombin Market: Dosage Form Segment Analysis
- Liquid
- Lyophilized
Global Antithrombin Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Alzheimer’s Drugs Market: https://www.zionmarketresearch.com/report/alzheimers-drugs-market
- Non-Invasive Prenatal Testing (NIPT) Market: https://www.zionmarketresearch.com/report/non-invasive-prenatal-testing-market
- Veterinary Anti-Infectives Market: https://www.zionmarketresearch.com/report/veterinary-anti-infectives-market
- Acromegaly Treatment Market: https://www.zionmarketresearch.com/report/acromegaly-treatment-market
- Melanoma Drugs Market: https://www.zionmarketresearch.com/report/melanoma-drugs-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research